Vedolizumab Experience in Children and Adolescents with Inflammatory Bowel Disease: A Multicenter Observational Study.
Hajjat, TM; Mosha, M; Whaley, KG; Rosen, MJ; Suppa, C; Markowitz, J; Dufour, L; Sauer, C; Shukla-Udawatta, M; Boyle, B; et al.
Crohn's && Colitis 360.
2021;
3.
Serologic Evaluation of Celiac Disease for Patients Younger Than 2 Years of Age.
Mallon, D; Hajjat, TM.
Journal of Pediatrics.
2020;
224:16-17.
Mo1796 – Vedolizumab Experience in Children and Adolescents with Inflammatory Bowel Disease: A Multicenter Observational Study (VOLCANO).
Hajjat, T; Mosha, MH; Suppa, C; Markowitz, J; Whaley, KG; Rosen, MJ; Shukla-Udawatta, M; Boyle, BM; Hunter, G; Perez, ME; et al.
Gastroenterology.
2019;
156.
882 – Normalization of Fecal Calprotectin Requires Higher Trough Infliximab Levels in Children with Inflammatory Bowel Disease.
Hajjat, T; Mosha, MH; Bonkowski, E; Denson, LA; Hyams, JS.
Gastroenterology.
2019;
156:s-200.
497 - Irrespective of Initial Ulcerative Colitis Therapy Thiopurines Unlikely to Result in Corticosteroid-Free Remission One Year after Diagnosis.
Hajjat, T; Wang, Z; Rufo, PA; Strople, JA; Sauer, CG; Markowitz, J; Pfefferkorn, MD; Oliva-Hemker, M; Rosh, JR; Otley, A; et al.
Gastroenterology.
2018;
154:s-113.
Differences in Durability, Dislodgement, and Other Complications With Use of Low-Profile Nonballoon Gastrostomy Tubes in Children.
Hajjat, T; Rahhal, RM.
Nutrition in Clinical Practice.
2017;
32:219-224.